![](/img/cover-not-exists.png)
Randomized Phase IIIb Trial Evaluating the Continuation of Bevacizumab Beyond Disease Progression in Patients with Advanced Non-Squamous Non–Small-Cell Lung Cancer after First-Line Treatment with Bevacizumab Plus Platinum-Based Chemotherapy: Treatment Rationale and Protocol Dynamics of the AvaALL (MO22097) Trial
Cesare Gridelli, Jaafar Bennouna, Javier de Castro, Anne-Marie C. Dingemans, Frank Griesinger, Francesco Grossi, Antonio Rossi, Nick Thatcher, Elaine K. Wong, Corey LangerVolume:
12
Year:
2011
Language:
english
Pages:
5
DOI:
10.1016/j.cllc.2011.05.002
File:
PDF, 268 KB
english, 2011